We are live on ! Find out more
CGON icon

CG Oncology
CGON

96 hedge funds and large institutions have $1.7B invested in CG Oncology in 2024 Q1 according to their latest regulatory filings, with 96 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

88.84% more ownership

Funds ownership: 0% → 88.84% (+89%)

45% less call options, than puts

Call options by funds: $48K | Put options by funds: $88K

Holders
96
Holders Change
+96
Holders Change %
–
% of All Funds
1.38%
Holding in Top 10
5
Holding in Top 10 Change
+5
Holding in Top 10 Change %
% of All Funds
0.07%
New
96
Increased
–
Reduced
–
Closed
–
Calls
$48K
Puts
$88K
Net Calls
-$40K
Net Calls Change
-$40K

Top Buyers

Rank Fund Capital Flow
1
DC
Decheng Capital
California
+$223M
2
TCM
TCG Crossover Management
California
+$146M
3
BlackRock
BlackRock
New York
+$103M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$90.9M
5
BI
BVF Inc
California
+$77M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
RI
26
RTW Investments
New York
$18.2M +$16.9M +413,670 New
State Street
27
State Street
Massachusetts
$15.4M +$14.3M +350,831 New
VA
28
VR Adviser
New York
$15.4M +$14.3M +350,000 New
ABG
29
Ally Bridge Group
New York
$14.1M +$13.1M +320,378 New
AIG
30
American International Group
New York
$13.4M +$12.5M +306,226 New
LGM
31
Logos Global Management
California
$13.2M +$12.3M +300,000 New
Citadel Advisors
32
Citadel Advisors
Florida
$12.1M +$11.3M +276,461 New
Massachusetts Financial Services
33
Massachusetts Financial Services
Massachusetts
$11.4M +$10.6M +259,888 New
TCM
34
TimesSquare Capital Management
New York
$9.84M +$9.15M +224,073 New
SCM
35
Soleus Capital Management
Connecticut
$9.56M +$8.9M +217,871 New
Wellington Management Group
36
Wellington Management Group
Massachusetts
$8.73M +$8.12M +198,807 New
ACH
37
ArrowMark Colorado Holdings
Colorado
$8.61M +$8.01M +196,107 New
Point72 Asset Management
38
Point72 Asset Management
Connecticut
$8.18M +$7.61M +186,237 New
Northern Trust
39
Northern Trust
Illinois
$8.03M +$7.47M +183,004 New
RSCM
40
Rock Springs Capital Management
Maryland
$7.5M +$6.98M +170,859 New
Charles Schwab
41
Charles Schwab
California
$7.43M +$6.92M +169,352 New
MIM
42
Monashee Investment Management
Massachusetts
$5.49M +$5.11M +125,000 New
DCM
43
Driehaus Capital Management
Illinois
$4.74M +$4.41M +107,957 New
Walleye Capital
44
Walleye Capital
New York
$4.67M +$4.34M +106,319 New
Jane Street
45
Jane Street
New York
$3.35M +$3.12M +76,353 New
GTC
46
Ghost Tree Capital
New York
$3.29M +$3.06M +75,000 New
Morgan Stanley
47
Morgan Stanley
New York
$3.24M +$3.01M +73,724 New
Bank of New York Mellon
48
Bank of New York Mellon
New York
$2.83M +$2.64M +64,543 New
Manulife (Manufacturers Life Insurance)
49
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$2.8M +$2.6M +63,774 New
N
50
Nuveen
North Carolina
$2.72M +$2.53M +61,866 New
1
2
3 4

CGON Hedge Fund Activity: Q1 2024 in Review

96 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in CG Oncology (CGON) for Q1 2024, worth a combined $1.7B.

Buyers outnumbered sellers: 96 funds opened new CGON positions and 0 closed out — a net gain of 96 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Decheng Capital, opening a new position worth an estimated $223M.

  • 96 institutional investors held CG Oncology (CGON) as of Q1 2024, up from 0 in Q4 2023.
  • Funds reported $1.7B of CG Oncology stock for Q1 2024.
  • 96 funds opened new CG Oncology positions in Q1 2024 and 0 closed out, a net change of +96 holders.
  • The largest CG Oncology buyer in Q1 2024 was Decheng Capital, an estimated $223M added.

Based on aggregated 13F filings for Q1 2024.